Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer.

Del Rivero J, Edgerly M, Ward J, Madan RA, Balasubramaniam S, Fojo T, Gramza AW.

Oncologist. 2019 Jan;24(1):16-e14. doi: 10.1634/theoncologist.2018-0452. Epub 2018 Oct 8.

2.

Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial.

Smallridge RC, Copland JA, Brose MS, Wadsworth JT, Houvras Y, Menefee ME, Bible KC, Shah MH, Gramza AW, Klopper JP, Marlow LA, Heckman MG, Von Roemeling R.

J Clin Endocrinol Metab. 2013 Jun;98(6):2392-400. doi: 10.1210/jc.2013-1106. Epub 2013 Apr 15.

3.

Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors.

Gramza AW, Corless CL, Heinrich MC.

Clin Cancer Res. 2009 Dec 15;15(24):7510-7518.

4.

Efficient method for preparing normal and tumor tissue for RNA extraction.

Gramza AW, Lucas JM, Mountain RE, Schuller DE, Lang JC.

Biotechniques. 1995 Feb;18(2):228-31. No abstract available.

PMID:
7537049

Supplemental Content

Loading ...
Support Center